The National Heart, Lung, and Blood Institute (NHLBI) awarded a $728,781 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to the University of Washington to test the effectiveness and implementation of a home-based exercise intervention called Exercise-ICD (E-ICD) for individuals with implantable cardioverter defibrillators (ICDs). The 5-year study involves a randomized controlled trial with 210 participants across 3 sites in the Seattle area, measuring the impact of the E-ICD intervention on physical activity, quality of life, and other outcomes compared to usual care. The project also aims to evaluate the reach, adoption, and implementation of the E-ICD program by cardiac rehabilitation clinical staff. The goal is to improve physical activity and health-related outcomes for ICD patients through an evidence-based, scalable exercise intervention.
Generated 3/4/25, 7:25 AM